MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$1,475K Marketable securities$14,399K Cash and cashequivalents$47,371K Other assets$392K Right-of-use asset -operating lease$939K Property and equipment,net$480K Total current assets$63,245K Total assets$65,056K Total liabilities andstockholders equity$65,056K Total stockholdersequity$50,920K Total liabilities$14,136K Accumulated deficit-$461,043K Treasury stock, at cost,4,522 shares of common...$3,968K Accumulated othercomprehensive income$13K Additional paid-in capital$515,878K Operating leaseobligation - non-current...$431K Deferred revenue -non-current portion$176K Total currentliabilities$13,529K Common stock, 0.001 parvalue 325,000,000...$40K Operating leaseobligation - current...$617K Deferred revenue -current portion$1,999K Note payable$379K Accrued expenses$9,254K Accounts payable$1,280K
Balance Sheet
source: myfinsight.com

Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics, Inc. (VTGN)